Tenon Medical Regains Nasdaq Compliance After Reverse Stock Split
Tenon Medical regained compliance with Nasdaq minimum bid price requirements following a 1-for-35 reverse stock split.
Tenon Medical, Inc. regained compliance with the minimum bid price requirements of the Nasdaq Stock Market LLC on August 24, 2026. The company had been in violation of the exchange's rules since February 25, 2026, when it received notice that its common stock closing bid price had remained below $1.00 per share for 30 consecutive business days.
To address the deficiency, the company executed a 1-for-35 reverse stock split that took effect on August 10, 2026. This action successfully raised the share price, which then maintained a closing bid price of $1.00 or greater for 10 consecutive business days ending August 21, 2026.
Nasdaq notified the company in writing that it has regained compliance and the matter is now closed. Tenon Medical continues to trade on the Nasdaq Capital Market under the ticker symbol TNON.